Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

Figure 1

Phase contrast photomicrographs of fibroblasts in culture, inoculated with chlamydia for 24 hours. Panel A. No NM added, cells filled with large inclusion bodies. Panel B. 5 μg/mL of NM added, variations of inclusion sizes seen. Panel C. 10 μg/mL of NM added, inclusions are much smaller. Panel D. 50 μg/mL of NM added, no inclusion bodies present. NM, nafamostat mesylate.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us